Dominant suppression of Addison's disease associated with HLA-B15

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 7, 2011, Pages 2154-2162

  Baker, Peter R ^a   Baschal, Erin E ^a   Fain, Pam R ^a   Nanduri, Priyaanka ^a   Triolo, Taylor M ^a   Siebert, Janet C ^b   Armstrong, Taylor K ^a   Babu, Sunanda R ^a   Rewers, Marian J ^a   Gottlieb, Peter A ^a   Barker, Jennifer M ^a   Eisenbarth, George S ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b CytoAnalytics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA B15 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; STEROID 21 MONOOXYGENASE; UNCLASSIFIED DRUG;

ADDISON DISEASE; ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENOTYPE; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADDISON DISEASE; ADULT; ALLELES; AUTOANTIBODIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HLA-B ANTIGENS; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; STEROID 21-HYDROXYLASE;

EID: 79960101432     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2010-2964     Document Type: Article

References (40)

1. Erichsen MM, Løvås K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J, Fougner KJ, Berg TJ, Bollerslev J, Mella B, Carlson JA, Erlich H, Husebye ES 2009 Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab 94:4882-4890
2. Betterle C, Dal Pra C, Mantero F, Zanchetta R 2002 Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 23:327-364 (Pubitemid 34651950)
3. Eisenbarth GS, Gottlieb PA 2004 Autoimmune polyendocrine syndromes. N Engl J Med 350:2068-2079
4. Falorni A, Laureti S, De Bellis A, Zanchetta R, Tiberti C, Arnaldi G, Bini V, Beck-Peccoz P, Bizzarro A, Dotta F, Mantero F, Bellastella A, Betterle C, Santeusanio F 2004 Italian addison network study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency. J Clin Endocrinol Metab 89:1598-1604 (Pubitemid 38507908)
5. Badenhoop K, Walfish PG, Rau H, Fischer S, Nicolay A, Bogner U, Schleusener H, Usadel KH 1995 Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J Clin Endocrinol Metab 80:2112-2117
6. Alper CA, Larsen CE, Dubey DP, Awdeh ZL, Fici DA, Yunis EJ 2006 The haplotype structure of the human major histocompatibility complex. Hum Immunol 67:73-84 (Pubitemid 43673910)
7. Gambelunghe G, Falorni A, Ghaderi M, Laureti S, Tortoioli C, Santeusanio F, Brunetti P, Sanjeevi CB 1999 Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease. J Clin Endocrinol Metab 84:3701-3707 (Pubitemid 30645228)
8. Gombos Z, Hermann R, Kiviniemi M, Nejentsev S, Reimand K, Fadeyev V, Peterson P, Uibo R, Ilonen J 2007 Analysis of extended human leukocyte antigen haplotype association with Addison's disease in three populations. Eur J Endocrinol 157:757-761
9. Weetman AP, Zhang L, Tandon N, Edwards OM 1991 HLA associations with autoimmune Addison's disease. Tissue Antigens 38: 31-33
10. Yu L, Brewer KW, Gates S, Wu A, Wang T, Babu SR, Gottlieb PA, Freed BM, Noble J, Erlich HA, Rewers MJ, Eisenbarth GS 1999 DRB1*04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease. J Clin Endocrinol Metab 84:328-335 (Pubitemid 29036722)
11. Neufeld M, Maclaren NK, Blizzard RM 1981 Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine (Baltimore) 60:355-362 (Pubitemid 12247574)
12. Bilbao JR, Martín-Pagola A, Pérez De Nanclares G, Calvo B, Vitoria JC, Vázquez F, Castaño L 2003 HLA-DRB1 and MICA in autoimmunity: common associated alleles in autoimmune disorders. Ann NY Acad Sci 1005:314-318 (Pubitemid 38507776)
13. Aly TA, Ide A, Jahromi MM, Barker JM, Fernando MS, Babu SR, Yu L, Miao D, Erlich HA, Fain PR, Barriga KJ, Norris JM, Rewers MJ, Eisenbarth GS 2006 Extreme genetic risk for type 1a diabetes. Proc Natl Acad Sci USA 103:14074-14079 (Pubitemid 44452982)
14. Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, Mychaleckyj JC, Todd JA, Bonella P, Fear AL, Lavant E, Louey A, Moonsamy P 2008 HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the Type 1 Diabetes Genetics Consortium Families. Diabetes 57:1084-1092
15. Gambelunghe G, Kockum I, Bini V, De Giorgi G, Celi F, Betterle C, Giordano R, Libè R, Falorni A 2005 Retrovirus-like long-terminal repeat DQ-LTR13 and genetic susceptibility to type 1 diabetes and autoimmune Addison's disease. Diabetes 54:900-905 (Pubitemid 40326266)
16. Eisenbarth G, Wilson P, Ward F, Lebovitz HE 1978 HLA type and occurrence of disease in familial polyglandular failure. N Engl J Med 298:92-94
17. Baker PR, Baschal EE, Fain PR, Triolo TM, Nanduri P, Siebert JC, Armstrong TK, Babu SR, Rewers MJ, Gottlieb PA, Barker JM, Eisenbarth GS 2010 Haplotype analysis discriminates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison's disease. J Clin Endocrinol Metab 95:E263-E270
18. Baschal EE, Aly TA, Jasinski JM, Steck AK, Noble JA, Erlich HA, Eisenbarth GS 2009 Defining multiple common "completely" conserved major histocompatibility complex SNP haplotypes. Clin Immunol 132:203-214
19. Meager A, Visvalingam K, Peterson P, Möll K, Murumägi A, Krohn K, Eskelin P, Perheentupa J, Husebye E, Kadota Y, Willcox N 2006 Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med 3:e289
20. Brown WM, Pierce J, Hilner JE, Perdue LH, Lohman K, Li L, Venkatesh RB, Hunt S, Mychaleckyj JC, Deloukas P; Type 1 Diabetes Genetics Consortium 2009 Overview of the MHC fine mapping data. Diabetes Obes Metab 11(Suppl 1):2-7
21. Rewers M, Bugawan TL, Norris JM, Blair A, Beaty B, Hoffman M, McDuffie RS Jr, Hamman RF, Klingensmith G, Eisenbarth GS, Erlich HA 1996 Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia 39:807-812 (Pubitemid 26228110)
22. Bugawan TL, Erlich HA 1991 Rapid typing of HLA-DQB1 DNA polymorphism using nonradioactive oligonucleotide probes and amplified DNA. Immunogenetics 33:163-170
23. Zake LN, Ghaderi M, Park YS, Babu S, Eisenbarth G, Sanjeevi CB 2002 MHC class I chain-related gene alleles 5 and 5.1 are transmitted more frequently to type 1 diabetes offspring in HBDI families. Ann NY Acad Sci 958:309-311 (Pubitemid 34592251)
24. Park YS, Sanjeevi CB, Robles D, Yu L, Rewers M, Gottlieb PA, Fain P, Eisenbarth GS 2002 Additional association of intra-MHC genes, MICA and D6S273, with Addison's disease. Tissue Antigens 60: 155-163 (Pubitemid 35314512)
25. Triolo TM, Baschal EE, Armstrong TK, Toews CS, Fain PR, Rewers MJ, Yu L, Miao D, Eisenbarth GS, Gottlieb PA, Barker JM 2009 Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes. J Clin Endocrinol Metab 94:4517-4523
26. Robinson J, Pérez-Rodríguez M, Waller MJ, Cuillerier B, Bahram S, Yao Z, Albert ED, Madrigal JA, Marsh SG 2001 MICA sequences 2000. Immunogenetics 53:150-169
27. Barker JM, Triolo TM, Aly TA, Baschal EE, Babu SR, Kretowski A, Rewers MJ, Eisenbarth GS 2008 Two single nucleotide polymorphisms identify the highest-risk diabetes HLA genotype: potential for rapid screening. Diabetes 57:3152-3155
28. Noble JA, Valdes AM, Bugawan TL, Apple RJ, Thomson G, Erlich HA 2002 The HLA class I A locus affects susceptibility to type 1 diabetes. Hum Immunol 63:657-664 (Pubitemid 34816108)
29. Valdes AM, Erlich HA, Noble JA 2005 Human leukocyte antigen class I B and Cloci contribute to type 1 diabetes (T1D) susceptibility and age T1D onset. Hum Immunol 66:301-313 (Pubitemid 40395251)
30. Nejentsev S, Howson JM, Walker NM, Szeszko J, Field SF, Stevens HE, Reynolds P, Hardy M, King E, Masters J, Hulme J, Maier LM, Smyth D, Bailey R, Cooper JD, Ribas G, Campbell RD, Clayton DG, Todd JA 2007 Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450:887-892 (Pubitemid 350231332)
31. Howson JM, Walker NM, Clayton D, Todd JA 2009 Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A. Diabetes Obes Metab 11(Suppl 1):31-45
32. Gonzalez-Gay MA, Rueda B, Vilchez JR, Lopez-Nevot MA, Robledo G, Ruiz MP, Fernández O, Garcia-Porrua C, Gonzalez-Escribano MF, Martín J 2007 Contribution of MHC class I region to genetic susceptibility for giant cell arteritis. Rheumatology (Oxford) 46:431-434 (Pubitemid 46344653)
33. Roshna T, Thomas R, Nandakumar K, Banerjee M 2006 A case-control study on the association of human leukocyte antigen-A*9 and -B*15 alleles with generalized aggressive periodontitis in an Indian population. J Periodontol 77:1954-1963 (Pubitemid 46002073)
34. Sia C, Weinem M 2005 The role of HLA class I gene variation in autoimmune diabetes. Rev Diabet Stud 2:97-109
35. Bisikirska B, Colgan J, Luban J, Bluestone JA, Herold KC 2005 TCR stimulation with modified anti-CD3 mAb expands CD8 T cell population and induces CD8CD25 Tregs. J Clin Invest 115:2904-2913 (Pubitemid 41434418)
36. Issazadeh S, Kjellén P, Olsson T, Mustafa M, Holmdahl R 1997 Major histocompatibility complex-controlled protective influences on experimental autoimmune encephalomyelitis are peptide specific. Eur J Immunol 27:1584-1587 (Pubitemid 27254855)
37. Schmidt D, Verdaguer J, Averill N, Santamaria P 1997Amechanism for the major histocompatibility complex-linked resistance to autoimmunity. J Exp Med 186:1059-1075
38. Madakamutil LT, Maricic I, Sercarz E, Kumar V 2003 Regulatory T cells control autoimmunity in vivo by inducing apoptotic depletion of activated pathogenic lymphocytes. J Immunol 170:2985-2992
39. Kaas Q, Ruiz M, Lefranc MP 2004 IMGT/3Dstructure-DB and IMGT/Structural Query, a database and a tool for immunoglobulin, T cell receptor and MHC structural data. Nucleic Acids Res 32: D208-D210 (Pubitemid 38081640)
40. Ehrenmann F, Kaas Q, Lefranc MP 2010 IMGT/3Dstructure-DB and IMGT/DomainGapAlign: a database and a tool for immunoglobulins or antibodies, T cell receptors, MHC, IgSF and MhcSF. Nucleic Acids Res 38:D301-D307